Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial
Embryonal tumors with multilayered rosettes (ETMR) are highly aggressive tumors occurring in early childhood. Published clinical data refer to retrospective, heterogeneously treated cohorts. Here, we describe the outcome of patients treated according to the prospective P-HIT trial and subsequent HIT...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
January 2022
|
| In: |
Neuro-Oncology
Year: 2022, Jahrgang: 24, Heft: 1, Pages: 127-137 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/noab100 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1093/neuonc/noab100
|
| Verfasserangaben: | B.-Ole Juhnke, Marco Gessi, Nicolas U. Gerber, Carsten Friedrich, Martin Mynarek, André O. von Bueren, Christine Haberler, Ulrich Schüller, Rolf-Dieter Kortmann, Beate Timmermann, Brigitte Bison, Monika Warmuth-Metz, Robert Kwiecien, Stefan M. Pfister, Claudia Spix, Torsten Pietsch, Marcel Kool, Stefan Rutkowski, and Katja von Hoff |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 180069539X | ||
| 003 | DE-627 | ||
| 005 | 20230707004231.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220502s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/neuonc/noab100 |2 doi | |
| 035 | |a (DE-627)180069539X | ||
| 035 | |a (DE-599)KXP180069539X | ||
| 035 | |a (OCoLC)1389536641 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Juhnke, Björn-Ole |e VerfasserIn |0 (DE-588)1138729248 |0 (DE-627)896284042 |0 (DE-576)492671389 |4 aut | |
| 245 | 1 | 0 | |a Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial |c B.-Ole Juhnke, Marco Gessi, Nicolas U. Gerber, Carsten Friedrich, Martin Mynarek, André O. von Bueren, Christine Haberler, Ulrich Schüller, Rolf-Dieter Kortmann, Beate Timmermann, Brigitte Bison, Monika Warmuth-Metz, Robert Kwiecien, Stefan M. Pfister, Claudia Spix, Torsten Pietsch, Marcel Kool, Stefan Rutkowski, and Katja von Hoff |
| 264 | 1 | |c January 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.01.2023 | ||
| 500 | |a Published: 28 April 2021 | ||
| 520 | |a Embryonal tumors with multilayered rosettes (ETMR) are highly aggressive tumors occurring in early childhood. Published clinical data refer to retrospective, heterogeneously treated cohorts. Here, we describe the outcome of patients treated according to the prospective P-HIT trial and subsequent HIT2000-interim-registry.Age-stratified treatment included carboplatin/etoposide induction, tandem high-dose chemotherapy (“CARBO/ETO + HDCT”), and response-stratified radiotherapy. Patients with centrally reviewed neuropathological and molecularly confirmed diagnosis of ETMR recruited within the P-HIT trial (2001-2011; n = 19), the HIT2000-interim-registry (2012-2014; n = 12), and earlier HIT trials (n = 4) were selected for analysis.Age-adjusted incidence rate was 1.35 per 1 million children (aged 1-4 years) in the years 2012-2014. Median age at diagnosis for 35 patients was 2.9 years. Metastases at diagnosis were detected in 9 patients. One patient died due to postoperative complications. For 30 patients with non-brainstem tumor location, 5-year progression-free survival (PFS) and overall survival (OS) were 35% and 47% after treatment with CARBO/ETO + HDCT (n = 17), compared to 0% and 8% with other treatments (n = 13, P[OS] = .011). All 4 patients with brainstem tumor died within 10 months after diagnosis. By multivariable analysis, supratentorial location: (HR [PFS]: 0.07 [95%CI: 0.01-0.38], P = .003), localized disease (M0): (HR [OS] M0, no residual tumor: 0.30 [95%CI: 0.009-1.09], P = .068; M0, residual tumor: 0.18 [95%CI: 0.04-0.76], P = .020), and CARBO/ETO + HDCT treatment (HR [OS]: 0.16 [95%CI: 0.05-054], P = .003) were identified as independent prognostic factors. Of 9 survivors, 6 were treated with radiotherapy (craniospinal 4; local 2).Our data indicate improved survival with intensified chemotherapy (CARBO/ETO + HDCT). However, despite intensive treatment, the outcome was poor. Thus, innovative therapies need to be evaluated urgently in an upfront setting. | ||
| 700 | 1 | |a Gessi, Marco |e VerfasserIn |0 (DE-588)1148034595 |0 (DE-627)1007516003 |0 (DE-576)496165690 |4 aut | |
| 700 | 1 | |a Gerber, Nicolas U. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Friedrich, Carsten |d 1978- |e VerfasserIn |0 (DE-588)1205319778 |0 (DE-627)1690893877 |4 aut | |
| 700 | 1 | |a Mynarek, Martin |d 1980- |e VerfasserIn |0 (DE-588)139768912 |0 (DE-627)613094255 |0 (DE-576)313038295 |4 aut | |
| 700 | 1 | |a Bueren, André von |e VerfasserIn |0 (DE-588)1027425445 |0 (DE-627)729125017 |0 (DE-576)373208502 |4 aut | |
| 700 | 1 | |a Haberler, Christine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schüller, Ulrich |d 1976- |e VerfasserIn |0 (DE-588)124391257 |0 (DE-627)363315063 |0 (DE-576)294150757 |4 aut | |
| 700 | 1 | |a Kortmann, Rolf-Dieter |e VerfasserIn |0 (DE-588)119965437X |0 (DE-627)1681979071 |4 aut | |
| 700 | 1 | |a Timmermann, Beate |d 1967- |e VerfasserIn |0 (DE-588)122476190 |0 (DE-627)705923010 |0 (DE-576)183247264 |4 aut | |
| 700 | 1 | |a Bison, Brigitte |d 1964- |e VerfasserIn |0 (DE-588)120166445 |0 (DE-627)696438410 |0 (DE-576)292074913 |4 aut | |
| 700 | 1 | |a Warmuth-Metz, Monika |e VerfasserIn |0 (DE-588)1158886195 |0 (DE-627)102109854X |0 (DE-576)504508334 |4 aut | |
| 700 | 1 | |a Kwiecien, Robert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfister, Stefan |d 1974- |e VerfasserIn |0 (DE-588)123850215 |0 (DE-627)706450930 |0 (DE-576)293908400 |4 aut | |
| 700 | 1 | |a Spix, Claudia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pietsch, Torsten |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kool, Marcel |e VerfasserIn |0 (DE-588)1058669753 |0 (DE-627)797393560 |0 (DE-576)414823842 |4 aut | |
| 700 | 1 | |a Rutkowski, Stefan |d 1965- |e VerfasserIn |0 (DE-588)114616108 |0 (DE-627)527107506 |0 (DE-576)289803004 |4 aut | |
| 700 | 1 | |a Hoff, Katja von |e VerfasserIn |0 (DE-588)1027430309 |0 (DE-627)729136205 |0 (DE-576)373215975 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-Oncology |d Oxford : Oxford Univ. Press, 1999 |g 24(2022), 1, Seite 127-137 |h Online-Ressource |w (DE-627)357167341 |w (DE-600)2094060-9 |w (DE-576)318041839 |x 1523-5866 |7 nnas |a Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial |
| 773 | 1 | 8 | |g volume:24 |g year:2022 |g number:1 |g pages:127-137 |g extent:11 |a Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial |
| 856 | 4 | 0 | |u https://doi.org/10.1093/neuonc/noab100 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230124 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1058669753 |a Kool, Marcel |m 1058669753:Kool, Marcel |d 50000 |e 50000PK1058669753 |k 0/50000/ |p 17 | ||
| 998 | |g 123850215 |a Pfister, Stefan |m 123850215:Pfister, Stefan |d 910000 |d 910500 |e 910000PP123850215 |e 910500PP123850215 |k 0/910000/ |k 1/910000/910500/ |p 14 | ||
| 999 | |a KXP-PPN180069539X |e 4251197550 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"note":["Gesehen am 24.01.2023","Published: 28 April 2021"],"relHost":[{"title":[{"title_sort":"Neuro-Oncology","subtitle":"official journal of the World Federation of Neuro-Oncology","title":"Neuro-Oncology"}],"disp":"Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trialNeuro-Oncology","language":["eng"],"note":["Gesehen am 21.07.23"],"part":{"extent":"11","text":"24(2022), 1, Seite 127-137","volume":"24","issue":"1","pages":"127-137","year":"2022"},"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1999 -"],"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisher":"Oxford Univ. Press ; Duke University Medical Center","publisherPlace":"Oxford ; Durham, NC"}],"recId":"357167341","id":{"eki":["357167341"],"zdb":["2094060-9"],"issn":["1523-5866"]}}],"physDesc":[{"extent":"11 S."}],"origin":[{"dateIssuedDisp":"January 2022","dateIssuedKey":"2022"}],"title":[{"title":"Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial","title_sort":"Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and highdose chemotherapy within the prospective P-HIT trial"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"roleDisplay":"VerfasserIn","display":"Juhnke, Björn-Ole","given":"Björn-Ole","family":"Juhnke","role":"aut"},{"role":"aut","family":"Gessi","roleDisplay":"VerfasserIn","display":"Gessi, Marco","given":"Marco"},{"roleDisplay":"VerfasserIn","given":"Nicolas U.","display":"Gerber, Nicolas U.","family":"Gerber","role":"aut"},{"family":"Friedrich","given":"Carsten","roleDisplay":"VerfasserIn","display":"Friedrich, Carsten","role":"aut"},{"family":"Mynarek","roleDisplay":"VerfasserIn","display":"Mynarek, Martin","given":"Martin","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Bueren, André von","given":"André von","family":"Bueren"},{"family":"Haberler","display":"Haberler, Christine","roleDisplay":"VerfasserIn","given":"Christine","role":"aut"},{"role":"aut","display":"Schüller, Ulrich","roleDisplay":"VerfasserIn","given":"Ulrich","family":"Schüller"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kortmann, Rolf-Dieter","given":"Rolf-Dieter","family":"Kortmann"},{"family":"Timmermann","given":"Beate","roleDisplay":"VerfasserIn","display":"Timmermann, Beate","role":"aut"},{"given":"Brigitte","roleDisplay":"VerfasserIn","display":"Bison, Brigitte","family":"Bison","role":"aut"},{"role":"aut","display":"Warmuth-Metz, Monika","roleDisplay":"VerfasserIn","given":"Monika","family":"Warmuth-Metz"},{"role":"aut","family":"Kwiecien","display":"Kwiecien, Robert","roleDisplay":"VerfasserIn","given":"Robert"},{"family":"Pfister","given":"Stefan","roleDisplay":"VerfasserIn","display":"Pfister, Stefan","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Claudia","display":"Spix, Claudia","family":"Spix","role":"aut"},{"family":"Pietsch","roleDisplay":"VerfasserIn","display":"Pietsch, Torsten","given":"Torsten","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Kool, Marcel","given":"Marcel","family":"Kool","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Rutkowski, Stefan","given":"Stefan","family":"Rutkowski"},{"role":"aut","family":"Hoff","roleDisplay":"VerfasserIn","given":"Katja von","display":"Hoff, Katja von"}],"name":{"displayForm":["B.-Ole Juhnke, Marco Gessi, Nicolas U. Gerber, Carsten Friedrich, Martin Mynarek, André O. von Bueren, Christine Haberler, Ulrich Schüller, Rolf-Dieter Kortmann, Beate Timmermann, Brigitte Bison, Monika Warmuth-Metz, Robert Kwiecien, Stefan M. Pfister, Claudia Spix, Torsten Pietsch, Marcel Kool, Stefan Rutkowski, and Katja von Hoff"]},"id":{"doi":["10.1093/neuonc/noab100"],"eki":["180069539X"]},"recId":"180069539X"} | ||
| SRT | |a JUHNKEBJOETREATMENTO2022 | ||